Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 15, 2026
A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumors.
Journal: Investigational new drugs
Published: April 06, 2026
Immunotherapy-induced hypersensitivity reaction to red tattoo ink.
Journal: JAAD case reports
Published: January 19, 2026
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study.
Journal: EBioMedicine
Published: July 03, 2025
Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma.
Journal: Journal of Cancer
Published: May 20, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.
Journal: Cancer research communications
Published: May 14, 2025
The Utility of Preoperative PET/CT in Patients with Clinically High-Risk Melanoma.
Journal: Annals of surgical oncology
Published: May 02, 2025
Recurrent Melanoma in a Patient with Chronic Lymphocytic Leukemia (CLL) Presenting with an Apparent Co-Existing NRAS and BRAF Mutation: A Diagnostic and Treatment Conundrum.
Journal: International journal of molecular sciences
Published: December 05, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 13, 2024
Last Updated: 09/26/2026